Candidemia
Information
- Disease name
- Candidemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02244606 | Completed | Phase 2 | Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis | September 2014 | August 2016 |
| NCT00113191 | Completed | N/A | Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants | May 2004 | June 2006 |
| NCT00189709 | Completed | Phase 3 | Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia | August 2004 | July 2006 |
| NCT00413218 | Completed | Phase 3 | Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections | March 8, 2007 | March 3, 2015 |
| NCT00537329 | Completed | Phase 3 | Anidulafungin In Treatment Of Candidemia In Asian Subjects | January 2008 | March 2009 |
| NCT00548262 | Completed | Phase 4 | This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis | February 2008 | October 2009 |
| NCT00607763 | Completed | Phase 1 | Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug | October 2007 | October 2009 |
| NCT00608335 | Completed | Phase 1 | Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug | October 14, 2007 | September 8, 2011 |
| NCT00670657 | Completed | Phase 4 | CRITIC - Treatment of Candidemia and Invasive Candidiasis | May 2007 | January 2009 |
| NCT00739934 | Completed | Phase 2 | Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection | December 2008 | October 2009 |
| NCT00761267 | Completed | Phase 3 | Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis | February 2009 | February 2018 |
| NCT00802854 | Completed | Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV | March 2, 2012 | May 20, 2016 | |
| NCT00839540 | Completed | Phase 4 | Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins | December 2008 | May 2010 |
| NCT00105144 | Completed | Phase 3 | Study of Micafungin in Patients With Invasive Candidiasis or Candidemia | September 2004 | April 2006 |
| NCT00940017 | Completed | Phase 4 | A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects | September 2008 | October 2008 |
| NCT01174147 | Completed | A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093) | April 2010 | November 2012 | |
| NCT04148287 | Completed | Phase 2 | An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris | December 13, 2019 | December 31, 2020 |
| NCT03799172 | Completed | Echinocandins Versus Azoles for Candidemia Treatment | November 1, 2018 | September 1, 2019 | |
| NCT03667690 | Completed | Phase 3 | Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis | October 7, 2018 | October 7, 2021 |
| NCT03604705 | Completed | Phase 2 | An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia | October 3, 2018 | July 2, 2020 |
| NCT01281345 | Completed | SIHAM Candidemia Network:An Observational Study | April 2011 | December 2012 | |
| NCT01406093 | Completed | Early- and Late-onset Candidemia | May 2011 | June 2012 | |
| NCT03363841 | Completed | Phase 3 | Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES) | November 15, 2017 | May 24, 2023 |
| NCT01525095 | Completed | Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT) | January 2012 | March 2014 | |
| NCT02841501 | Completed | Genetic Susceptibility Factors for Candidemia. | June 2013 | June 25, 2020 | |
| NCT01734525 | Completed | Phase 4 | Negative Beta Glucan in ICU Patients | November 2012 | December 2013 |
| NCT01752166 | Completed | Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study) | July 2013 | April 2014 | |
| NCT02734862 | Completed | Phase 2 | CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension | July 26, 2016 | July 2019 |
| NCT02088476 | Completed | Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal | January 2004 | June 2013 | |
| NCT02163889 | Completed | Serial Therapeutic and Antifungal Monitoring Protocol | September 2014 | April 2017 | |
| NCT05421858 | Not yet recruiting | Phase 3 | A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis | July 15, 2024 | July 15, 2027 |
| NCT04368559 | Recruiting | Phase 3 | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation | May 11, 2020 | August 2024 |
| NCT04979052 | Recruiting | Phase 2 | Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia | March 31, 2022 | January 2025 |
| NCT05178862 | Suspended | Phase 3 | A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole | August 3, 2022 | August 2024 |
| NCT01213823 | Terminated | Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins | September 2008 | May 2011 | |
| NCT01176058 | Terminated | Phase 3 | A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis | December 2010 | November 2011 |
| NCT01982071 | Terminated | Phase 4 | A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia | September 26, 2013 | August 28, 2015 |
| NCT00903526 | Unknown status | Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care Hospital | March 2009 | ||
| NCT01438216 | Unknown status | Anidulafungin Pharmacokinetics in Intensive Care Unit Patients | September 2011 | March 2012 | |
| NCT01270490 | Unknown status | Phase 3 | Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia | January 2011 | |
| NCT01249313 | Unknown status | Risk Factor and Outcome of Candidemia | September 2011 | December 2012 | |
| NCT04147975 | Unknown status | Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood | October 1, 2019 | October 30, 2020 | |
| NCT01622595 | Withdrawn | UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients | November 2009 | December 2015 | |
| NCT02333266 | Withdrawn | Bio-assay Development and Implementation for Fungal Infection Detection | June 2016 |
- MedGen concept unique identifier (MedGen Concept name)
- C0877445
- MedGen unique identifier (MedGen Concept name)
- 163760
- MeSH unique ID (MeSH (Medical Subject Headings))
- D058387